Walgreens Commits $2.3 Mil. To Settle Pseudoephedrine Sale Complaint
This article was originally published in The Tan Sheet
Walgreens agreed to a $1.3 mil. fee July 28 to settle government allegations that the company had violated state and federal laws regulating the sale of pseudoephedrine
You may also be interested in...
The Senate Judiciary Committee unanimously passed the Combat Meth Act of 2005 (S 103) July 28 after adopting an amendment that strikes the federal preemption provision from the bill
A wave of decisions from leading OTC drug retailers to place pseudoephedrine solids behind the counter could provide momentum for a federal pseudoephedrine BTC bill
Legislation restricting the sale of pseudoephedrine tablets to licensed pharmacies was signed into law in Oklahoma on April 7 and is being considered by other states looking to adopt similar measures